Idorsia Ltd (Over The Counter Market:IDRSF)
| 8.65 Delayed Data As of 12:00am ET |  +0.15 / +1.76%Today’s Change | 8.50 Today|||52-Week Range 19.14 | -41.12% Year-to-Date |
Latest IDRSF News | Press Releases
No recent news for Idorsia Ltd.
Today’s Trading
| Previous close | 8.50 |
| Today’s open | 8.65 |
| Day’s range | 8.65 - 8.65 |
| Volume | 1,420 |
| Average volume (3 months) | 1,402 |
| Market cap | $1.7B |
Data as of 06/01/2023
Growth & Valuation
| Earnings growth (last year) | -18.60% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +162.96% |
| P/E ratio | -- |
| Price/Sales | 25.31 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | +0.27 | +1.97% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| OASMYVivesto AB | 0.00 | 0.00% |
Data as of 3:59pm ET, 06/01/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $101.7M |
| Annual profit (last year) | -$866.8M |
| Net profit margin | -852.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Allschwil, Basel-landschaft (basle Country) |
Forecasts
Chart unavailable
